Market Cap 3.77B 1B 886M 838M 760M 1.43B 96.32B 1.44B 10.05B 3.88B 49.19B 3.69B 158B P/E 2026 *
16.8x
P/E 2027 * 14.6x
Enterprise Value 4.75B 1.27B 1.12B 1.06B 958M 1.8B 121B 1.81B 12.67B 4.88B 62B 4.65B 200B EV / Sales 2026 *
2.61x
EV / Sales 2027 * 2.4x
Free-Float
88.97%
Yield 2026 *
1.52%
Yield 2027 * 2.89%
1 day+0.25%
1 week-2.11%
Current month+4.16%
1 month+2.07%
3 months+10.50%
6 months+5.48%
Current year+21.18%
1 week 31.44
Extreme 31.44
33.32
1 month 30
Extreme 30
33.32
Current year 24.96
Extreme 24.96
33.32
1 year 24.96
Extreme 24.96
33.32
3 years 20.94
Extreme 20.94
42.85
5 years 20.94
Extreme 20.94
47.3
10 years 20.94
Extreme 20.94
61.4
Manager TitleAgeSince
Chief Executive Officer 58 05/01/2021
Chief Executive Officer - 07/04/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 03/04/2016
Director/Board Member - 03/04/2019
Director/Board Member - 03/04/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.25%-2.11%+7.20%-10.54% 1B
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 655B
-1.12%-0.72%+17.98%+76.63% 471B
-1.72%-4.06%+36.39%+39.47% 342B
-0.40%+3.83%+22.08%+28.82% 277B
-0.51%-1.93%+12.09%+11.94% 257B
+1.32%+3.27%+54.63%+57.63% 226B
-0.61%-0.91%+34.33%+101.87% 189B
-0.24%-2.76%-28.41%-60.92% 170B
Average -0.14%+0.50%+26.67%+43.72% 364.39B
Weighted average by Cap. -0.05%+0.81%+38.90%+70.50%

Financials

2026 *2027 *
Net sales 1.82B 484M 427M 404M 367M 687M 46.45B 694M 4.85B 1.87B 23.72B 1.78B 76.33B 1.92B 512M 452M 428M 388M 727M 49.16B 734M 5.13B 1.98B 25.1B 1.88B 80.78B
Net income 225M 60.01M 52.96M 50.11M 45.44M 85.2M 5.76B 86.04M 601M 232M 2.94B 220M 9.46B 260M 69.28M 61.14M 57.85M 52.46M 98.36M 6.65B 99.33M 694M 267M 3.39B 254M 10.92B
Net Debt 982M 262M 231M 218M 198M 371M 25.1B 375M 2.62B 1.01B 12.82B 961M 41.24B 846M 225M 199M 188M 171M 320M 21.63B 323M 2.26B 870M 11.04B 828M 35.54B
Logo Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corp SPIMACO ADDWAEIH SJSC is a Saudi Arabia based pharmaceutical company. The Company is primarily engaged in manufacturing of pharmaceutical products, medicines for human use and wholesale and retail of medicines and related products, development and marketing of medical and pharmaceutical products, research and development in medical science activities, operating and maintaining the healthcare facilities and any investments in related industries. The Company is organized into four segments which include Pharmaceutical Manufacturing, Trading and Distribution Services, Healthcare Services and Discontinued Operation. Products of the Company include tablets, capsules, syrups and suspensions, injections, creams, ointments and gels, suppositories, mouthwash and antiseptic products. The Subsidiaries of the Company include ARACOM Medical Company, Dammam Pharmaceutical Company, SPIMACO Misr Company for Distribution and others.
Employees
-
Date Price Change Volume
29/09/26 SAR 31.58 +0.25% 400,322
28/09/26 SAR 31.50 -0.63% 175,889
27/09/26 SAR 31.70 -2.46% 210,509
24/09/26 SAR 32.50 -0.73% 617,385
22/09/26 SAR 32.74 +1.49% 348,038
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
31.58SAR
Average target price
34.05SAR
Spread / Average Target
+7.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 2070 Stock